Clinical Trial Update: Platelet Transfusion for Treatment of Patent Ductus Arteriosus in Thrombocytopenic Preterm Neonates [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating platelet transfusion as a treatment for patent ductus arteriosus in thrombocytopenic preterm neonates has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Patent Ductus Arteriosus

Drugs mentioned

• Platelet transfusion (platelet transfusion)

Snippet

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh | Conditions: Patent Ductus Arteriosus | Phase 3 | Status: COMPLETED